AU723405B2 - Fermented dairy product - Google Patents
Fermented dairy product Download PDFInfo
- Publication number
- AU723405B2 AU723405B2 AU54789/98A AU5478998A AU723405B2 AU 723405 B2 AU723405 B2 AU 723405B2 AU 54789/98 A AU54789/98 A AU 54789/98A AU 5478998 A AU5478998 A AU 5478998A AU 723405 B2 AU723405 B2 AU 723405B2
- Authority
- AU
- Australia
- Prior art keywords
- milk
- lactic acid
- acid bacteria
- fermented
- redox potential
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/13—Fermented milk preparations; Treatment using microorganisms or enzymes using additives
- A23C9/1322—Inorganic compounds; Minerals, including organic salts thereof, oligo-elements; Amino-acids, peptides, protein-hydrolysates or derivatives; Nucleic acids or derivatives; Yeast extract or autolysate; Vitamins; Antibiotics; Bacteriocins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
- A23C19/00—Cheese; Cheese preparations; Making thereof
- A23C19/02—Making cheese curd
- A23C19/05—Treating milk before coagulation; Separating whey from curd
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
- A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Microbiology (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Nutrition Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Dairy Products (AREA)
Description
-1- Fermented dairy product The subject of the present invention is a new process for the preparation of a fermented milk composition.
State of the art Although lactic acid bacteria are generally known to have beneficial effects on human health, only certain categories of lactic acid bacteria are really capable of adhering to the human intestinal cells, of excluding pathogenic bacteria from human intestinal cells, and/or of acting on the human immune system by allowing it to react more strongly to external attacks. Lactic acid bacteria are termed "probiotic" if they 10 possess at least one of these characteristics.
To date, relatively few lactic acid bacteria are truly probiotic bacteria. For i example, the strains Lactobacillus casei ATCC53103, Lactobacillus acidophilus CNCM go I-1225, Bifidobacterium breve CNCM 1-1226, Bifidobacterium infantis CNCM I-1227 and Bifidobacterium longum CNCM 1-1228, have thus been scientifically recognized as 15 being probiotic bacteria since they are capable of adhering to human intestinal cells, of excluding pathogenic bacteria from human intestinal cells, and of acting on the human immune system (EP577904; EP577903; EP199535, Gut, 35, 483-489, 1994; J. of Dairy Science, 78, 491-197, 1995; Applied Env. Microb., 59, 4121-4128, 1993).
The probiotic lactic acid bacteria are often also extremely sensitive to oxygen because of their adaptation to the anaerobic living conditions found in the intestinal tract.
Furthermore, these bacteria grow poorly in milk, which poses problems for obtaining a sufficient level of lactic acid bacteria in a fermented dairy product.
22393-00.DOC -2- To enhance the growth of slow-growing lactic acid bacteria, EP 154614 suggests increasing the load of the started culture during the inoculation of a milk, and also adding to this milk growth activators such as yeast extracts or whey proteins, for example.
Although it is possible to solve, by this means, the problems of growth in milk, the probiotic lactic acid bacteria unfortunately still remain very sensitive to the conditions for the processing and preservation of a fermented milk. Indeed, most of the plastic packagings used to package diary products are permeable to oxygen. Furthermore, the subsequent processing of a fermented milk, for example to fromage blanc or to liquid 10 acidified milks, requires stirring of the milk in the presence of air, which increases the level of oxygen in the final product.
It is an object of the present invention to overcome or ameliorate at least one of the disadvantages of the prior art, or to provide a useful alternative.
o0 0 Summary of the invention Is According to a first aspect, the invention provides a process for the manufacture of a fermented milk composition in which a milk is pasteurized at a temperature and for a period such that its redox potential at 25C is reduced to a value of less than 450 mvolt, agents which stabilize the redox potential of the milk are added, the milk is inoculated with lactic acid bacteria, the milk is fermented until at least 106 cfu/ml and an Aw greater than 0.97 are obtained.
According to a second aspect, the invention provides use of a milk having a redox potential at 25 0 C of less than 450 mvolt and containing agents which stabilize this 22393-00ooDOC 2a redox potential of the milk, for the preparation of a fermented dairy product by lactic acid bacteria.
According to a third aspect, the invention provides milk compositions packaged in a material which is impermeable or semipermeable to oxygen, the said compositions having a redox potential of less than 450 mvolt and an Aw greater than 0.97, and at least 106 cfu/ml of probiotic lactic acid bacteria.
Unless the context clearly requires otherwise, throughout the description and the claims, the words 'comprise', 'comprising', and the like are to be construed in an inclusive sense as opposed to an exclusive or exhaustive sense; that is to say, in the sense 10 of "including, but not limited to".
S
Cfu comes from the expression "colony forming unit".
y.
*X
22393-00.DOC 3 Finally, the invention also relates to the use of a fermented dairy composition derived from the present process in the preparation of a dairy product comprising lactic acid bacteria.
Against all expectations, the lactic acid bacteria which are known to be sensitive to the conditions for fermentation and preservation of a milk, for example which are sensitive to the presence of air, in fact become more resistant to these conditions, and in particular become tolerant to the presence of air, as long as the redox potential of the milk in which they live is less than about 450 mvolt. This resistance results in a better bacterial development during the fermentation of a milk, and a better survival of the bacteria during the preservation of the fermented milk.
Although this redox potential can be adjusted by various means, it has been found that a prolonged pasteurization of the milk is sufficient to obtain a required redox potential. Indeed, a prolonged heat treatment makes it possible to break certain milk proteins and thus release reducing groups. Furthermore, this treatment makes it possible to cause the proteins and the milk sugars to react so that the reducing compounds derived from Maillard reactions are formed.
This pasteurization has other advantages.
Firstly, a prolonged treatment of the milk at high temperatures promotes degassing of the milk, and therefore a low oxygen content in the milk. Secondly, this treatment makes it possible to convert a portion of the milk lactose to lactulose which is known to stimulate the growth of certain lactic acid bacteria.
Brief description of the figures Figure-i. represents, after fermentation, the number of cells of the CNCM 1-1225 strain (cfu/ml) having grown in various milks, the said milks having undergone various heat treatments before fermentation, the said fermented milks having been stored for 1 or 28 days at refrigeration temperatures, and the said 4 fermented milks having also been packaged in glass or polystyrene packagings.
Figure 2 represents, after fermentation, the number of cells of the CNCM 1-1225 strain (cfu/ml) having grown in various milks, the said milks having a redox potential of the order of 500 mvolt or -50 mvolt before fermentation, and the said fermentation having been carried out under aerobic or anaerobic conditions.
Figure 3 represents the number of cells of the CNCM 1-1225 strain (cfu/ml) having grown in various milks, as well as the redox potential at 250C of these fermented milks, as a function of the duration of storage of these fermented milks at refrigeration temperatures.
Detailed description of the invention Within the framework of the present invention, the name "rennet" is given to the coagulating extract obtained from the abomasum of young ruminants slaughtered before weaning. It will be assumed that rennet also covers calf rennet substitutes such as animal pepsins; the coagulating preparations obtained from the plant kingdom extracted from artichoke, thistle, ficin, latex, fig, papain, for example; the coagulating preparations obtained from the microbial kingdom extracted from bacteria of the genus Bacillus and Pseudomonas, and moulds belonging to the species Endothia parasitica, Mucor pusillus and Mucor miehei, for example.
Milk is intended to designate, on the one hand, a milk of animal origin, such as cow's, goat's, sheep's, buffalo's, zebra's, horse's, ass's and camel's milk and the like. This milk may be a milk in the native state, a reconstituted milk, a skimmed milk, or a milk supplemented with compounds necessary for the growth of the bacteria or for the treatment of the milk, such as fats, yeast extract, peptone, ascorbic acid and/or a surfactant, for example. Preferably, 5 these milks have a pH of the order of 6.4-7, in particular pH 6.6-6.8.
The term milk also applies to what is commonly called a vegetable milk, that is to say an-extract of plant materials, treated or otherwise, such as legumes (soya bean, chickpea, lentil and the like) or oilseeds (rapeseed, soya bean, sesame, cotton and the like), which extract contains proteins in solution or in colloidal suspension, coagulable by chemical action, by acid fermentation and/or by heat. It has been possible to subject these vegetable milks to heat treatments similar to those for animal milks. It has also been possible to subject them to treatments which are specific to them, such as decolorization, deodorization, and treatments for eliminating undesirable tastes. Finally, the word milk also designates mixtures of animal milks and of vegetable milks. Preferably, these milks have a pH of the order of 6.4-7, in particular pH 6.6-6.8.
Against all expectations, it has been found that the growth and the survival of certain lactic acid bacteria are also influenced by the water activity of the milk that is to say the ratio between the partial vapour pressure of the water at the surface of the powder and the vapour pressure of pure water at the same temperature. The best survival levels may be obtained when the Aw of the milk at 20 0 C is greater than 0.97, preferably between 0.988-0.983, for example.
As a guide, the Aw may be determined by measuring the equilibrium relative humidity reached in a closed vessel at constant temperature. For that, a sample of a few g of milk is enclosed in a leaktight container placed in a thermostatted chamber at 20 0 C. The empty space around this sample reaches, at equilibrium, after 30-60 min, the same Aw value as the sample. An electronic sensor, mounted in the lid of the container, then measures the humidity in this empty space by means of an electrolytic resistance.
6 Likewise, it has been found that the addition, to the milk, of at least one bacterial growth promoting agent made it possible to substantially increase the growth and survival of certain lactic acid bacteria.
Among these agents, there may be mentioned in particular a sugar such as glucose and sucrose, an amino acid such as cysteine and glutathione, a yeast extract, in particular an extract comprising large quantities of purine and pyrimidine bases as well as their phosphate derivatives (adenosine, thymine, guanine, cytosine and uracil) and/or hydrolysates of animal or plant (soya) protein materials, for example.
In particular, the milk may comprise about 0.1-1% of yeast extract and/or about 0.25-1% of peptones.
Because it has been realized that the redox potential of a dairy product comprising lactic acid bacteria is capable of being substantially increased during the storage of the dairy product at refrigeration temperatures, it is also preferable to add to the milk compounds which are capable of stabilizing its redox potential. Among these compounds, there may be mentioned all dietary reducing agents such as ascorbic acid, vitamin E and/or their derivatives, which can be used in an amount of 0.01-1% by weight, for example.
The compounds which stabilize the redox potential and the agents which promote bacterial growth may be added to the milk before pasteurization.
However, because some of these compounds can be destroyed or even modified following a prolonged heat treatment, it is also possible to envisage adding them to the milk after pasteurization and/or after fermentation, in the form of a sterile solution, for example.
All the devices intended for pasteurizing a milk may be used by persons skilled in the art. It is thus possible to heat treat the milk at at least 90 0
C
for at least 30 min, preferably at 95-130 0 C for 120 min, so as to obtain a redox potential of less than 7 450 mvolt, in particular of less than 400 mvolt, or even of less than 350 mvolt if it is desired to obtain maximum growth and survival of the lactic acid bacteria, for example.
Next, the pasteurized milk is inoculated with at least one strain of lactic acid bacteria so as to directly obtain in the milk from 103 to 108 cfu/ml. It is possible to inoculate the milk with a fresh culture of lactic acid bacteria, with a concentrated and frozen culture, or even with a culture dried by lyophilization or by spraying under a stream of hot air (see US389730), for example.
The strain of lactic acid bacteria may be chosen from the species Lactococcus lactis in particular L. lactis subsp. cremoris, L. lactis subsp.
lactic biovar diacetylactis, and L. lactis; Streptococcus thermophilus; the acidophilic bacteria comprising L. acidophilus, L. crispatus, L. amylovorous, L.
gallinarum, L. gasseri, L. johnsonii; Lactobacillus fermentum; Lactobacillus casei in particular L. casei subsp. casei; Lactobacillus delbruckii in particular L. delbruckii subsp. lactis; L. delbruckii subsp.
helveticus; L. delbruckii subsp. bulgaricus; the bifidobacteria, in particular Bifidobacterium infantis, Bifidobacterium breve; Bifidobacterium longum; and finally Leuconostoc mesenteroides in particular L.
mesenteroides subsp. cremoris, for example (Bergey's Manual of Systematic Bacteriology, Vol. 2, 1986; Fujisawa et al., Int. Syst. Bact, 42, 487-491, 1992).
Preferably, lactic acid bacteria are used which are sensitive to oxygen, in particular all the bifidobacteria, Lactobacillus acidophilus, Lactobacillus johnsonii, Lactobacillus gasseri, Lactobacillus fermentum, Lactobacillus casei, Lactobacillus bulgaricus and Lactobacillus helveticus.
The probiotic bacteria are of special interest within the framework of the present invention. These bacteria are in fact capable of adhering to human k intestinal cells, of excluding pathogenic bacteria from 8 human intestinal cells, and of acting on the human immune system by allowing it to react more strongly to external attacks (immunomodulation capacity), for example by increasing the phagocytosis capacities of the granulocytes derived from human blood of Dairy Science, 78, 491-197 [sic], 1995: immunomodulation capacity of the La-1 strain which has been deposited at the Pasteur Institute under the number CNCM 1-1225).
By way of example, it is possible to use the Lactobacillus acidophilus CNCM 1-1225 strain described in EP577904. This strain was recently reclassified among the Lactobacillus johnsonii, following the new taxonomy, proposed by Fujisawa et al., which is now authoritative in the field of taxonomy of acidophilic lactobacilli (Int. J. Syst. Bact., 42, 487-791, 1992).
Other probiotic bacteria are also available, such as those described in EP199535 (Gorbach et al.) or in US5296221 (Mitsuoka et for example.
The milk composition obtained by the process according to the invention may also be traditionally fermented until at least 106 cfu/ml, in particular 107-109 cfu/ml, are obtained, for example. When these milk compositions comprise probiotic lactic acid bacteria, in particular the L. johnsonii CNCM 1-1225 strain, it is preferable to carry out the fermentation in the absence of oxygen, for example under a carbon dioxide atmosphere.
The milk composition obtained by the process according to the invention may also be converted to unripened fromage frais which are commonly called "quarg" or "cottage cheese" in Anglo-Saxon countries and "quark" in Germany, for example. For that, it is possible to ferment the milk inoculated with lactic acid bacteria, but not necessarily. Rennet, of the order of 0.01 to 0.15% by volume/volume, is generally added to it so as to cause the casein to pass from a colloidal phase to a precipitated phase, this passage being accompanied by the formation of a whey. Next, the whey is separated by centrifugation or ultrafiltration.
9 The invention also covers all milk compositions packaged in a material which is impermeable or semipermeable to -oxygen, the said compositions comprising at least 106 cfu/ml of probiotic lactic acid bacteria and a redox potential of less than 450 mvolt, preferably of less than 400-350 mvolt if compositions are desired in which the viability of the lactic acid bacteria is stabilized at an acceptable level.
Preferably, the milk compositions according to the invention are packaged in a material which allows the passage of less than 0.01 cm 3 of air per day and per cm 2 under an external pressure of 0.21 bar, for example a material which is impermeable to air such as glass or ethyl vinyl alcohol (EVOH), or a material which is semipermeable to air such as polystyrene (PS), polypropylene polyethylene terephthalate (PET), ethyl vinyl alcohol (EVOH), high-density polyethylene (HDPE), or a mixture of these materials, for example.
Because the lactic acid bacteria which exist in a milk treated according to the present process become particularly resistant to stress situations, the milk composition obtained by the present process can also be used to prepare other fermented dairy products, in particular as a starter for a fermentation of a milk on a large scale, for example.
The present invention is described in greater detail below with the aid of the additional description which follows, which refers to examples of preparation of fermented dairy products, as well as to the description of a test for measuring the redox potential. The percentages and parts are given by weight unless otherwise stated. It goes without saying, however, that these examples are given by way of illustration of the subject of the invention and do not constitute in any manner a limitation thereto.
Measurement of the redox potential The measurement of the redox potential is carried out in accordance with the publication by 10 Buhler H. et al. (Ingold Germany). For that, a pH/mvolt-meter combined with a redox electrode (Ingold No. 105053288) is used. The pH/mvolt-meter is calibrated using a standard redox buffer. The milk samples at pH 6.4-7 are incubated beforehand on a bath at 25 0 C. The measurement of the redox potential is carried out after 3 min of stability, and the redox potential is calculated by adding 244.4 mvolt to the redox value displayed.
Example 1 Several milk samples consisting of 10% of a skimmed milk powder, 1% of yeast extracts and 0.5% of glucose are prepared. In order to obtain redox potentials of less than 450 mvolt, these milks are heat-treated, respectively, for 30 min at 63 0 C on a hot water bath, for 30 min at 950C on a hot water bath, for min at 1210C in an autoclave, or for 60 min at 1210C in an autoclave. These milks are inoculated with the probiotic strain Lactobacillus johnsonii CNCM 1-1225 which was deposited at the Pasteur Institute, 25 rue du docteur Roux, Paris, 30 June 1992. These milks are fermented without stirring until a pH of the order of 4.6 is obtained, they are each packaged in two impermeable (glass) or semipermeable packagings, each packaged milk is stored for 1 day or 28 days at refrigeration temperatures, and then after storage, the number of lactic acid bacteria which survive is determined.
The results presented in Figure 1 clearly show that the prolonged heat treatment of the milk substantially enhances the survival of the lactic acid bacteria, even in the presence of oxygen. Moreover, it is also observed that the redox potentials of the heattreated milks are inversely correlated with time and with the temperature level applied to the milk. In other words, the more extensive the heat treatment of the milk, the lower the redox potential of the milk. In this regard, it should thus be noted that the lower the 11 redox potential of the milk, the more manifest the resistance of the lactic acid bacteria.
Example 2 The redox potentials at 250C of two artificial MRS media are adjusted respectively to about 500 mvolt and -50 mvolt, by adding thereto an appropriate quantity of potassium ferricynide [sic] or of DTT.
These two media are inoculated with an inoculum of the Lactobacillus johnsonii CNCM 1-1225 strain, and they are fermented under aerobic conditions. For the aerobic conditions, sterile air bubbles are introduced into the fermentation media. Finally, the number of bacterial colonies which have grown in these milks is counted.
The results presented in Figure 2 show that the milks having a redox potential at 250C of the order of mvolt give the best growth scores, whether in the absence or in the presence of air. Consequently, when the redox potential of a milk is reduced, the growth of certain lactic acid bacteria is thereby promoted.
Example 3 Two starters are prepared from the Lactobacillus johnsonii CNCM 1-1225 strain and from the Streptococcus thermophilus CNCM 1-1421 strain which was deposited at the Pasteur Institute, 25 rue du docteur Roux, Paris, 18 May 1994, in a milk consisting of of a skimmed milk powder, 1% of yeast extract and of glucose, the said milk having previously been heattreated at 95 0 C for 30 min.
A skimmed milk conventionally pasteurized at 115 0 C for 20 min is inoculated with 5% of the Lactobacillus johnsonii CNCM 1-1225 strain starter and with 0.5% of the Streptococcus thermophilus CNCM 1-1421 strain starter. When the pH of the fermented milks reaches pH 4.5, 0.1% weight/volume of vitamin C is added, the milks are packaged in pots which are semipermeable to air and they are stored at refrigeration temperatures for 1, 14 or 28 days, after 12 which the redox potential of the fermented milks is measured and the number of Lactobacillus johnsonii CNCM 1-1225 bacteria which have survived in these fermented milks is counted.
For comparison, a milk is fermented under the same conditions, the only difference being that vitamin C is not added.
The results presented in Figure 3 show that if the redox potential of a fermented milk is reduced to and stabilized at month of [sic] 450 mvolt, a survival rate of the lactic acid bacteria of at least 50% is obtained after 28 days of storage; whereas if the redox potential of the fermented milk is greater than 450 mvolt, less than 1% survival is obtained after 28 days of storage.
Example 4 Two milks consisting of 10% of a skimmed milk powder and various concentrations of yeast extracts are prepared, these media are heat-treated at 1150C for min, they are inoculated with 5% of a fresh culture of the Lactobacillus johnsonii CNCM 1-1225 strain, they are incubated at 400C for 1 to 28 days, and the number of lactic acid bacteria which have survived these storage conditions is determined.
For comparison, milks fermented and stored for 1 to 28 days are analysed, the said milks comprising no yeast extracts.
The results show that the user [sic] of 0.1 to 1% of yeast extracts in the culture medium promotes the survival of the lactic acid bacteria during prolonged storage of this medium. The best results are obtained for milks having of the order of 1% of yeast extracts.
Example Several milks containing 10% of a skimmed milk powder and various concentrations of additives are prepared, these media are heat-treated at 1150C for min, they are inoculated with 5% of a fresh culture of 13 the Lactobacillus johnsonii CNCM 1-1225 strain, they are incubated at 40 0 C until a pH of 4.5 is obtained, they are cooled to 4 0 C for 28 days in pots which are permeable to air or semipermeable to air, and the number of lactic acid bacteria which have survived these storage conditions is determined. The experimental conditions are given in Table 1 below. It should however be noted that vitamin C is added after fermentation and before storage, in the form of a sterile solution.
The results presented in Table 1 below show that the peptone extracts, the yeast extracts and/or the vitamin C make it possible to enhance the survival of the probiotic lactic acid bacteria after 28 days of storage at refrigeration temperatures, even in the presence of air.
14 Table 1 Media Packaging survival after 28 days of a skimmed milk powder, permeable 0.22 1% of yeast extract, 0.5% of semipermeable 14.03 glucose of a skimmed milk powder, permeable 2.47 1% of yeast extract, 0.5% of semipermeable 21.18 glucose, and 0.01% of vitamin C of a skimmed milk powder, permeable 0.34 1% of yeast extract, 0.25% of semipermeable 10.55 peptone, and 0.01% of vitamin C of a skimmed milk powder, permeable 1.72 1% of yeast extract, 0.25% of semipermeable 21.11 peptone, and 0.1% of vitamin C of a skimmed milk powder, permeable 28.09 1% of yeast extract, 0.25% of semipermeable 32.85 peptone, and 0.5% of vitamin C of a skimmed milk powder, permeable 31.81 1% of yeast extract, 0.25% of semipermeable 31.81 peptone, and 1% of vitamin C Example 6 Several milks are prepared skimmed milk powder, 1% of which consist of 10% of a yeast extracts and various concentrations of sucrose so as to adjust the water activity of the milk from 0.978 to 0.989. These media are heat-treated at 115 0 C for 15 min, they are inoculated with 5% of a fresh culture of the Lactobacillus johnsonii CNCM 1-1225 strain, they are incubated at 40 0 C until a pH of 4.5 is obtained, they are cooled to 4°C, they are stored at 4°C for 1 to 28 days in pots which are semipermeable to air, and the number of lactic acid bacteria which have survived these storage conditions is determined.
The results show that the lactic acid bacteria survive storage better for a prolonged period at 15 refrigeration temperatures when the Aw of the culture medium before fermentation is of the order of 0.985.
Claims (8)
- 2. Process according to Claim i, in which the milk comprises, in addition, bacterial growth promoting agents.
- 3. Process according to either of Claims 1 and 2, in which the milk is fermented by lactic acid bacteria capable of adhering to human intestinal cells, of excluding pathogenic bacteria from human intestinal cells, and of acting on the human immune system by allowing it to react more strongly to external attacks.
- 4. Use of a milk having a redox potential at 25 0 C of less than 450 mvolt and containing agents which stabilize this redox potential of the milk, for the preparation of a fermented dairy product by lactic acid bacteria. Use according to Claim 4, for the preparation of a dairy product packaged in a material which is impermeable or semipermeable to oxygen.
- 6. Milk compositions packaged in a material which is impermeable or semipermeable to oxygen, the said compositions having a redox potential of less than 450 mvolt and an Aw greater than 0.97, and at least 106 cfu/ml of probiotic lactic acid bacteria. -17-
- 7. A process for the manufacture of a fermented milk composition substantially as herein described with reference to any one of the examples, but excluding any comparative examples.
- 8. Use of milk substantially as herein described with reference to any one of the examples, but excluding any comparative examples.
- 9. A milk composition substantially as herein described with reference to any one of the examples, but excluding any comparative examples. DATEDthis 3rd Day of February 2000 SOCIETY DES PRODUITS NESTLE S.A. 10 Attorney: PAUL G. HARRISON Fellow Institute of Patent Attorneys of Australia of BALDWIN SHELSTON WATERS a
- 22393-00.DOC
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP96203708 | 1996-12-24 | ||
| EP96203708 | 1996-12-24 | ||
| PCT/EP1997/005577 WO1998027824A1 (en) | 1996-12-24 | 1997-11-26 | Fermented milk product |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU5478998A AU5478998A (en) | 1998-07-17 |
| AU723405B2 true AU723405B2 (en) | 2000-08-24 |
Family
ID=8224765
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU54789/98A Ceased AU723405B2 (en) | 1996-12-24 | 1997-11-26 | Fermented dairy product |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP0948262A1 (en) |
| AU (1) | AU723405B2 (en) |
| CA (1) | CA2274535A1 (en) |
| IL (1) | IL130285A0 (en) |
| WO (1) | WO1998027824A1 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2427566B1 (en) | 2009-05-05 | 2015-10-28 | Eurolactis Group S.A. | Probiotic microorganisms isolated from donkey milk |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0114400B8 (en) * | 2000-10-06 | 2021-05-25 | Nestle Sa | use of probiotic lactic acid bacteria to balance the skin's immune system |
| NL1020301C2 (en) * | 2002-04-04 | 2003-04-11 | Winclove Bio Ind B V | Production of a probiotic preparation comprises incubating a probiotic microorganism and a metabolizable substrate with an aqueous liquid |
| KR101149285B1 (en) | 2002-04-12 | 2012-05-24 | 가부시키가이샤 메이지 | Cheese capable of disinfecting helicobacter pylori |
| FR2884113B1 (en) * | 2005-04-06 | 2007-05-25 | Air Liquide | PROCESS FOR MODIFYING THE HYGIENIC, CHEMICAL AND SENSORY QUALITIES OF A CHEESE BY REDOX POTENTIAL CONTROL |
| FR2891634B1 (en) * | 2005-09-30 | 2013-12-06 | Air Liquide | PROCESS FOR MANUFACTURING A FOOD OR BIOTECHNOLOGICAL PRODUCT USING REDOX POTENTIAL REGULATION |
| ITTO20130265A1 (en) * | 2013-03-29 | 2014-09-30 | Consiglio Per La Ricerca E La Speri Mentazione In | CASE PRODUCT AND METHOD FOR THE PRODUCTION OF SUCH PRODUCT. |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0529414B1 (en) * | 1991-08-23 | 1995-11-15 | Kabushiki Kaisha Yakult Honsha | Fermented milk drinks and production process thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1799303A (en) * | 1929-04-12 | 1931-04-07 | Walter L Kulp | Method of making milk product |
| US1899817A (en) * | 1931-05-23 | 1933-02-28 | Abbotts Dairies Inc | Therapeutic milk product and process of making same |
| GB460972A (en) * | 1934-08-04 | 1937-02-08 | Lewis Kempton Mobley | Improvements in and relating to bacterial milk products |
| GB1110978A (en) * | 1965-07-06 | 1968-04-24 | Dairy Technics Inc | Mixed bacterial concentrates for the fermentation of milk |
| FR95476E (en) * | 1966-07-28 | 1971-01-15 | Kyowa Hakko Kogyo Kk | Bifidus factors as well as milk foods containing them and their manufacturing process. |
| NL9000422A (en) * | 1990-02-21 | 1991-09-16 | Nl Zuivelonderzoek Inst | METHOD FOR PREPARING A FERMENTED MILK PRODUCT |
-
1997
- 1997-11-26 CA CA002274535A patent/CA2274535A1/en not_active Abandoned
- 1997-11-26 EP EP97951127A patent/EP0948262A1/en not_active Withdrawn
- 1997-11-26 AU AU54789/98A patent/AU723405B2/en not_active Ceased
- 1997-11-26 IL IL13028597A patent/IL130285A0/en unknown
- 1997-11-26 WO PCT/EP1997/005577 patent/WO1998027824A1/en not_active Ceased
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0529414B1 (en) * | 1991-08-23 | 1995-11-15 | Kabushiki Kaisha Yakult Honsha | Fermented milk drinks and production process thereof |
Non-Patent Citations (1)
| Title |
|---|
| BRUNNER J., DMZ LEBEN. UND MILCH., 1993, 114(34): 981-986 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2427566B1 (en) | 2009-05-05 | 2015-10-28 | Eurolactis Group S.A. | Probiotic microorganisms isolated from donkey milk |
Also Published As
| Publication number | Publication date |
|---|---|
| IL130285A0 (en) | 2000-06-01 |
| WO1998027824A1 (en) | 1998-07-02 |
| EP0948262A1 (en) | 1999-10-13 |
| AU5478998A (en) | 1998-07-17 |
| CA2274535A1 (en) | 1998-07-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Champagne et al. | Challenges in the addition of probiotic cultures to foods | |
| Vedamuthu | Starter cultures for yogurt and fermented milks | |
| JP5898220B2 (en) | Lactic acid strains that modify texture | |
| US12584099B2 (en) | Method for preparing cultures of lactic acid bacteria | |
| EP1009243B1 (en) | Dairy starter culture delivery system and use hereof | |
| IE58827B1 (en) | Acid-resistant bifidobacteria | |
| KR20250010595A (en) | Phage-resistant lactic acid bacteria | |
| IE61010B1 (en) | Fermented milk products | |
| CN101489400A (en) | Cysteine granules and their use as growth stimulators for bifidobacterium animalis | |
| Mohammadi et al. | Aflatoxin M1 reduction by probiotic strains in Iranian Feta cheese | |
| Koutinas | Fermented dairy products | |
| AU723405B2 (en) | Fermented dairy product | |
| Madureira et al. | Incorporation and survival of probiotic bacteria in whey cheese matrices | |
| EP3975726A1 (en) | Process for producing a fermented milk product with an enhanced level of probiotics | |
| RU2337558C2 (en) | Starter for direct introduction into milk base and method of manufacturing fermented milk food products | |
| JP2022136018A (en) | Fermented composition with improved shape retention, and method for producing the same | |
| AU729924B2 (en) | Fromage frais | |
| JP2023549879A (en) | Lactic acid bacteria strain with improved textural properties | |
| El-Sayed et al. | Comparative evaluation of the microencapsulation methods efficiency to protect probiotic strains in simulated gastric conditions | |
| CA2563321C (en) | Process for seeding a media with microorganism in form of a tablet | |
| 玉井洋一 et al. | Antimutagenic Activity of the Milk Fermented by Mixed-Cultured with Various Lactic Acid Bacteria and a Yeast. | |
| Slačanac et al. | Production of antibacterial organic acids during the fermentation of goat and cow milk with Bifidobacterium longum Bb-46 | |
| JP2022120417A (en) | Fermentation composition improved in flavor, and method for producing the same | |
| Champagne | Development of fermented milk products containing probiotics | |
| Béal et al. | Production of laban |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) |